Delivery Order SPE2DE24D0021-SPE2D625F0CL5
- Not listed
- Fisher Scientific Company L.L.C. was awarded a $1,020 fixed-price delivery order with economic price adjustment on September 12, 2025, for PCR (polymerase chain reaction) platen superficial 2X master mix built-in kits. The contract is a child award under a larger federal vehicle and carries an ultimate completion date of October 6, 2025. Funding originates from the Medical Supply Chain division within the Department of Defense, with performance taking place in Pittsburgh, Pennsylvania. No...
- Fisher Scientific Company L.L.C., a major supplier of laboratory and medical equipment to federal agencies, received a $2,140.14 fixed-price delivery order from the Defense Department's Medical Supply Chain division on June 18, 2025. The contract covers procurement of a kit for real-time polymerase chain reaction (PCR) DNA polymerase, single-step substrate, and related 3-plate configuration materials. Performance will take place in Pittsburgh, Pennsylvania, with an ultimate completion date of...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $8,325.00 on August 22, 2025, for the procurement of PCR (polymerase chain reaction) IV 1st strand superscript reagents in 50 reaction quantities. This fixed-price contract with economic price adjustment provisions will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of September 5, 2025. The contract was awarded without set-aside designation through open competition to the Defense or Civilian...
- Fisher Scientific Company L.L.C. was awarded a delivery order on August 7, 2025, valued at $4,929.58 for the procurement of a real-time PCR (polymerase chain reaction) 1ml DNA multiplex master mix kit. This fixed-price delivery order with economic price adjustment terms is set to be completed by August 14, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract was awarded by the Medical Supply Chain division of the Department of Defense through open competition with no set-aside...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $17,174.10 on August 7, 2025, for the procurement of PCR (polymerase chain reaction) system reagents—specifically SYS PCR IV 1st Strain Superscript 50 reaction kits. This fixed-price delivery order with economic price adjustment is scheduled for completion by August 18, 2025, and will be performed at Fisher Scientific's location in Pittsburgh, PA. The contract was awarded without a set-aside designation, reflecting open...
- Fisher Scientific Company L.L.C. was awarded a $3,956.00 delivery order contract on June 18, 2025, for kit real-time polymerase chain reaction (RT PCR) RNA with 1 step builtin hot start gel. This fixed-price contract with economic price adjustment has an ultimate completion date of July 1, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract was awarded by the Medical Supply Chain, a defense-focused federal agency, with no set-aside designation applied. As a child contract...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,230.00 on August 22, 2025, for the procurement of a kit containing real-time polymerase chain reaction (PCR) DNA primer with a single-step protocol and probe for detection purposes. The contract, which is fixed price with economic price adjustment pricing, is classified as a child contract and was issued without a set-aside designation. The work will be performed in Pittsburgh, Pennsylvania, with an ultimate completion...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $17,597.93 on May 19, 2025, for the procurement of kit real-time polymerase chain reaction (PCR) RNA with one step built-in hot start gel supplies. This fixed-price delivery order with economic price adjustment has an ultimate completion date of May 30, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract was awarded by the Medical Supply Chain agency, a defense-focused federal entity, through an open...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order contract to Fisher Scientific Company L.L.C. on August 6, 2025, for direct polymerase chain reaction (PCR) reagents and kits, specifically MagMAX DNA products. This fixed-price delivery order with economic price adjustment carries a ceiling value of $1,952.64 and is scheduled for completion by August 18, 2025. The performance location is Pittsburgh, Pennsylvania. This award represents a child contract under a larger...
- Fisher Scientific Company L.L.C. was awarded a delivery order contract on August 5, 2025, for the supply of RT PCR 1ML DNA Multiplex Master Mix kits, with a ceiling value of $2,464.79. The contract utilizes fixed-price pricing with economic price adjustment and is classified as a child contract, indicating it falls under a larger contract vehicle. The place of performance is Pittsburgh, Pennsylvania, and the contract has an ultimate completion date of August 15, 2025. No set-aside designation...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F0CL5Delivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,702.00 by the Medical Supply Chain (a defense-focused federal agency) on June 2, 2025, for PCR polymerase chain reaction platin quantitative supermix with ROX at 500 reactions. This is a fixed-price contract with economic price adjustment provisions, with an ultimate completion date of June 5, 2025, and performance to be completed in Pittsburgh, Pennsylvania. The contract was awarded without any set-aside designation, reflecting open competition procurement. As a child contract, this delivery order likely falls under a larger blanket purchase agreement or multiple award schedule vehicle, consistent with Fisher Scientific's established federal contracting relationships. Fisher Scientific, a major supplier of laboratory supplies and scientific instruments to federal agencies since its 2001 SAM.gov registration, is well-positioned to fulfill this specialized molecular biology reagent requirement. The company's extensive contract history includes significant partnerships with agencies such as the National Institutes of Health and the Department of Veterans Affairs for laboratory and medical equipment procurement. The PCR supermix reagent being procured supports quantitative polymerase chain reaction applications commonly used in research, diagnostics, and testing operations across federal scientific and healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 6/2/25 |